Cargando…

Inhalable nanocatchers for SARS-CoV-2 inhibition

The global coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome (SARS)–like coronavirus (SARS-CoV-2), presents an urgent health crisis. More recently, an increasing number of mutated strains of SARS-CoV-2 have been identified globally. Such mutations, especially...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Han, Zhu, Wenjun, Jin, Qiutong, Pan, Feng, Zhu, Jiafei, Liu, Yanbin, Chen, Linfu, Shen, Jingjing, Yang, Yang, Chen, Qian, Liu, Zhuang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307760/ https://www.ncbi.nlm.nih.gov/pubmed/34292870 http://dx.doi.org/10.1073/pnas.2102957118

Ejemplares similares

Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
por: Zhou, Jun, et al.
Publicado: (2022)

Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment
por: Shen, Jingjing, et al.
Publicado: (2023)

Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2
por: Kang, Yuan-Lin, et al.
Publicado: (2020)

Tight junction protein occludin is an internalization factor for SARS-CoV-2 infection and mediates virus cell-to-cell transmission
por: Zhang, Jialin, et al.
Publicado: (2023)

Inhibition of duck hepatitis B virus replication by mimic peptides in vitro
por: JIA, HONGYU, et al.
Publicado: (2015)

SNX27 suppresses SARS-CoV-2 infection by inhibiting viral lysosome/late endosome entry
por: Yang, Bo, et al.
Publicado: (2022)

Targeting spike glycans to inhibit SARS-CoV2 viral entry
por: Guseman, Alex J., et al.
Publicado: (2023)

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
por: Xiong, Hualong, et al.
Publicado: (2022)

Nanometer-resolution in situ structure of the SARS-CoV-2 postfusion spike protein
por: Tai, Linhua, et al.
Publicado: (2021)

Cross-species recognition of SARS-CoV-2 to bat ACE2
por: Liu, Kefang, et al.
Publicado: (2021)

Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2
por: Zhao, Yao, et al.
Publicado: (2022)

Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
por: Li, Cheng, et al.
Publicado: (2022)

Enhanced inhibition of MHC-I expression by SARS-CoV-2 Omicron subvariants
por: Moriyama, Miyu, et al.
Publicado: (2023)

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential
por: Gai, Junwei, et al.
Publicado: (2021)

The ORF8 protein of SARS-CoV-2 mediates immune evasion through down-regulating MHC-Ι
por: Zhang, Yiwen, et al.
Publicado: (2021)

miR‐148b inhibits glycolysis in gastric cancer through targeting SLC2A1
por: Ding, Xiangfu, et al.
Publicado: (2017)

Mouse models susceptible to HCoV-229E and HCoV-NL63 and cross protection from challenge with SARS-CoV-2
por: Liu, Donglan, et al.
Publicado: (2023)

Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein
por: Yang, Kailu, et al.
Publicado: (2022)

Inhibition of elastase enhances the adjuvanticity of alum and promotes anti–SARS-CoV-2 systemic and mucosal immunity
por: Kim, Eunsoo, et al.
Publicado: (2021)

Bepridil is potent against SARS-CoV-2 in vitro
por: Vatansever, Erol C., et al.
Publicado: (2021)

Meclofenamic acid selectively inhibits FTO demethylation of m(6)A over ALKBH5
por: Huang, Yue, et al.
Publicado: (2015)

Passive inhaled mRNA vaccination for SARS-Cov-2
por: Yeo, Wee Song, et al.
Publicado: (2021)

The impact of inhaled corticosteroid on SARS-CoV2 infection
por: Lai, Chih-Cheng
Publicado: (2021)

In situ architecture and membrane fusion of SARS-CoV-2 Delta variant
por: Song, Yutong, et al.
Publicado: (2023)

SARS-CoV-2 infection induces activation of ferroptosis in human placenta
por: Wang, Bingbing, et al.
Publicado: (2022)

Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants
por: Li, Cun, et al.
Publicado: (2023)

Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
por: Yang, Qi, et al.
Publicado: (2020)

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
por: Liu, Juan, et al.
Publicado: (2023)

A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV-2 at the immune–epithelial interface
por: Leon, Juliette, et al.
Publicado: (2021)

Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells
por: Chen, Jian, et al.
Publicado: (2021)

Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs
por: Pan, Ke, et al.
Publicado: (2021)

Dromedary camel nanobodies broadly neutralize SARS-CoV-2 variants
por: Hong, Jessica, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

The global succinylation of SARS-CoV-2–infected host cells reveals drug targets
por: Liu, Quan, et al.
Publicado: (2022)

Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide
por: Wang, Zhiyu, et al.
Publicado: (2020)

The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients
por: Tang, Bufu, et al.
Publicado: (2020)

Prospects of Inhaled Phage Therapy for Combatting Pulmonary Infections
por: Wang, Xiang, et al.
Publicado: (2021)

SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis
por: Qin, Chao, et al.
Publicado: (2022)

Analysis of genomic distributions of SARS-CoV-2 reveals a dominant strain type with strong allelic associations
por: Yang, Hsin-Chou, et al.
Publicado: (2020)

Anthracyclines inhibit SARS-CoV-2 infection
por: Wang, Zhen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p5mhtvfrb4tcu0609jh0dhn2ru